Officials from the Therapeutic Goods Administration will join prescribers in Noosa next week for the third annual conference hosted by the Australian and New Zealand College of Cannabinoid Practitioners.
Office of Drug Control assistant secretary Avi Rebera and assistant director of the TGA’s medicinal cannabis regulatory reforms section, Deborah Greenbaum, will both attend the event which opens at Elysium Noosa Resort on May 29.
Under the theme ‘precision, compassion, evolution – the next chapter in cannabinoid medicine’, the conference will feature three days of debate and discussion and explore latest research and practical insights for clinical practice.
The gathering comes at a critical time for the industry which is facing the threat of regulatory reform, external scrutiny and falling prices.
ANZCCP vice president Dr Orit Holtzman said practitioners are under increasing pressure to show medicinal cannabis has a genuine role to play in healthcare.
“On both sides, clinicians are navigating prescribing standards, affordability barriers, and the pressure to demonstrate that this field deserves its place in legitimate healthcare,” she said.
“This is exactly why the ANZCCP conference exists. It brings together clinicians and researchers from across Australia and New Zealand doing this work at the coalface. If you’re a practitioner serious about raising the standard of care in this space, this is where you need to be.”
Along withpreviously announced speakers – including New Zealand-based acute care clinician and ANZCCP board member Dr Michael Murphy, Israeli researcher professor Dedi Meiri and palliative and supportive care specialist associate professor Judith Lacey – the event will welcome Medical Cannabis Australia clinical educator Luiza Guizan who will unravel the complexities of the national and state regulations, while Mandi Jacobson from law firm Thomson Geer will discuss the art of advertising without incurring the wrath of the regulator.
Other speakers include Dr Shiksha Gallow from South Africa who will address the conference about compassion in clinical cannabinoid practice, and Roei Zerahia from MSICS Pharma, also in Israel, who will present the latest psilocybin research.
Dr Jim Connell, nurse practitioner Lisa Dick, Dr David Gunn, assistance professor Daryl Efron, Dr Jeremy Lim and Dr Priya Ayyar will also address the conference.
Click here for more information and here to buy tickets.
